Once-daily indinavir plus ritonavir: preliminary results of the PIPO study

被引:8
作者
Burger, DM [1 ]
Hugen, PWH
van der Ende, ME
van Wijngaarden, P
Aarnoutse, RE
Reiss, P
Lange, JMA
机构
[1] Univ Nijmegen, Med Ctr, Dept Clin Pharm, Nijmegen, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands
[3] Univ Amsterdam, Dept Infect Dis Trop Med & AIDS, Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Int AIDS Therapy Evaluat Ctr, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1097/00002030-200011100-00032
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:2621 / 2623
页数:3
相关论文
共 5 条
  • [1] Indinavir concentrations and antiviral effect
    Acosta, EP
    Henry, K
    Baken, L
    Page, LM
    Fletcher, CV
    [J]. PHARMACOTHERAPY, 1999, 19 (06): : 708 - 712
  • [2] Burger DM, 1998, ANTIVIR THER, V3, P215
  • [3] BURGER DM, 1999, 39 INT C ANT AG CHEM
  • [4] Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography
    Hugen, PWH
    Verweij-van Wissen, CPWGM
    Burger, DM
    Wuis, EW
    Koopmans, PP
    Hekster, YA
    [J]. JOURNAL OF CHROMATOGRAPHY B, 1999, 727 (1-2): : 139 - 149
  • [5] SAAH A, 1999, 39 INT C ANT AG CHEM